Transdermal Delivery System for Tenofovir Alafenamide

Status:Stopped Early
Phase:Pre-clinical
Principal Investigator(s):
Objective:The aim of this study was to develop a transdermal patch containing TAF and investigate its performance in vitro through human epidermis.
Prevention Option(s):PrEP
Study Design:
Arms and Assigned Interventions
DescriptionMicroarray transdermal patch
Mode of Delivery
ARMs
Related Publications:
Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
Trial Sponsors: CONRAD, Corporation of Mercer University, Eastern Virginia Medical School, USAID/PEPFAR
Start Date
End Date
none
none
Enrollment:0
Age range: ↔ any
Population: